104
Participants
Start Date
July 8, 2022
Primary Completion Date
October 26, 2022
Study Completion Date
October 26, 2022
Remimazolam
0.075 mg/kg Remimazolam bolus infusion for 1 min, then 0.5\~1.0 mg/kg/h continuous infusion
Dexmedetomidine
1 mcg/kg Dexmedetomidine infusion for 10 min, then 0.2\~0.7 mcg/kg/h continuous infusion
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER